![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 39, 27573-27577, September 24, 1999
,
,
¶
From the Metabotropic glutamate receptor subtype 7 (mGluR7) is coupled to the inhibitory cyclic AMP cascade and is
selectively activated by a glutamate analogue,
L-2-amino-4-phosphonobutyrate. Among L-2-amino-4-phosphonobutyrate-sensitive mGluR subtypes,
mGluR7 is highly concentrated at the presynaptic terminals and is
thought to play an important role in modulation of glutamatergic
synaptic transmission by presynaptic inhibition of glutamate release.
To gain further insight into the intracellular signaling mechanisms of
mGluR7, with the aid of glutathione S-transferase fusion
affinity chromatography, we attempted to identify proteins that
interact with the intracellular carboxyl terminus of mGluR7. Here, we
report that calmodulin (CaM) directly binds to the carboxyl terminus of
mGluR7 in a Ca2+-dependent manner. The
CaM-binding domain is located immediately following the 7th
transmembrane segment. We also show that the CaM-binding domain of
mGluR7 is phosphorylated by protein kinase C (PKC). This
phosphorylation is inhibited by the binding of Ca2+/CaM to
the receptor. Conversely, the Ca2+/CaM binding is prevented
by PKC phosphorylation. Collectively, these results suggest that mGluR7
serves to cross-link the cyclic AMP, Ca2+, and PKC
phosphorylation signal transduction cascades.
Metabotropic glutamate receptors
(mGluRs)1 belong to the class
of seven transmembrane domain receptors and consist of eight different
subtypes (mGluR1 to mGluR8) (1-4). They are coupled to intracellular
signal transduction mechanisms via G proteins and exert their effects
on second messengers and ion channels (2-4). The eight mGluR subtypes
can be classified into three groups (2-4). Group 1 receptors (mGluR1
and mGluR5) are coupled to the stimulation of the inositol
trisphosphate (IP3)/Ca2+ signaling pathway.
Group 2 (mGluR2 and mGluR3) and group 3 (mGluR4, mGluR6, mGluR7, and
mGluR8) receptors are coupled to the inhibitory cyclic AMP cascade in
heterologously expressing cells but differ in their agonist
selectivity. Among the mGluR family, mGluR7 is the most highly
conserved across different mammalian species (5) and is widely
distributed throughout the central nervous system (6-9). This receptor
is selectively activated by L-2-amino-4-phosphonobutyrate (L-AP4) (10, 11). L-AP4 has been shown to exert
a potent presynaptic inhibition of glutamate release (12, 13). At
synapses, mGluR7 is located in close proximity to synaptic vesicle
release sites (9, 14, 15). Recent gene targeting analysis has indicated that mGluR7 deficiency causes a reduction in high frequency synaptic transmission, post-tetanic potentiation, and short term potentiation in
the CA1 synapses of hippocampal slices (16). In behavioral analyses,
these knockout mice showed a deficit in fear response and conditioned
taste aversion (17). Therefore, mGluR7 has been postulated to play an
important role in synaptic modulation and plasticity. However, it
remains elusive whether a variety of cellular and physiological
functions of mGluR7 all result from coupling to the inhibitory cyclic
AMP cascade mediated by this receptor subtype.
Recent biochemical and molecular studies have indicated that
protein-protein interactions play a pivotal role in regulation and
signal transduction of group 1 mGluRs (18-20). The identification of
molecules that interact with receptors would thus provide an important
clue for understanding the receptor function. In this study, we
attempted to identify proteins that interact with mGluR7 by glutathione
S-transferase (GST) affinity chromatography using the
intracellular carboxyl terminus of mGluR7 (ct-mGluR7). We show that a
17-kDa protein, which was identified as calmodulin (CaM), binds
directly to ct-mGluR7 in a Ca2+-dependent
manner. In addition, we show that the Ca2+/CaM binding is
inhibited by protein kinase C (PKC)-evoked phosphorylation. Furthermore, PKC phosphorylation of ct-mGluR7 is inhibited by Ca2+/CaM binding.
Materials--
Materials were purchased from the following
sources: bovine CaM from Sigma; mouse monoclonal antibody against CaM
(anti-CaM mAb) from Upstate Biotechnology, Inc. (Lake Placid, NY); rat
brain PKC from Calbiochem; catalytic subunit of bovine heart protein kinase A (PKA) from Roche Molecular Biochemicals;
[ Recombinant Proteins--
ct-mGluR2
(Gln820-Leu872), ct-mGluR3
(Gln829-Leu879), ct-mGluR4
(His848-Ile912), ct-mGluR6
(His840-Lys871),and ct-mGluR7
(His851-Ile915) were amplified, using the
corresponding mGluR cDNAs (10, 21, 22) as templates by polymerase
chain reaction (PCR). ct-mGluR8 (His844-Ile908)
was amplified with rat brain total RNA by reverse
transcriptase-mediated PCR (23). Primers for PCR or reverse
transcriptase-mediated PCR were designed as follows: the nucleotide
sequence immediately following the 7th transmembrane segment and
covering 19-21 base pairs of the downstream sequence of each
individual ct-mGluR was preceded by an appropriate restriction cleavage
site and used as a 5' primer. The sequence containing a stop codon and
the upstream sequence of each respective ct-mGluR was followed by a
restriction cleavage site and used as a 3' primer. GST fusion proteins
containing different ct-mGluRs (GST-ct-mGluRs) were generated by
inserting the PCR products in-frame into a multiple cloning site
downstream of the GST-coding region of the pGEX4T series of vectors
(Amersham Pharmacia Biotech). Truncated forms of ct-mGluR7 fused to the GST protein were similarly constructed by starting with an appropriate amino-terminal sequence in ct-mGluR7 and ending with the TAA stop codon. All ct or truncated forms of mGluR7 were designed to contain the
common linker amino acid sequence between GST and the inserts. A proper
in-frame insertion and the absence of any sequence errors of the PCR
products were confirmed by DNA sequencing in both strands of all
constructs. The GST fusion proteins were expressed in an Escherichia coli strain BL21 and purified by
glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech). The
GST-ct-mGluR7 protein was further purified by cation exchange
chromatography on a MonoS column (Amersham Pharmacia Biotech) using a
gradient elution from 150 to 405 mM NaCl in a solution
containing 50 mM Hepes, pH 7.0, 2 mM EDTA, and
1 mM dithiothreitol. Fractions containing the GST-ct-mGluR7 protein were combined, dialyzed against 25 mM Hepes, pH
7.4, containing 150 mM NaCl, and then concentrated with
Ultrafree (Millipore, Bedford, MA).
Affinity Chromatography of Brain Extracts--
Brains from adult
Sprague-Dawley rats were homogenized on ice using a glass-Teflon
homogenizer (20 strokes) in Buffer A (10 mM Hepes, pH 7.5, 150 mM NaCl, 2 µg/ml pepstatin, 2 µg/ml leupeptin, 2 µg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride)
and centrifuged at 100,000 × g for 1 h at
4 °C. The supernatant was precleared by passing through Sepharose 4B
beads. GST fusion proteins (100 µg) were immobilized on
glutathione-Sepharose 4B beads (50 µl) and incubated with the
precleared brain supernatant for 4 h at 4 °C. The beads were
washed with Buffer A five times, and bound proteins were eluted by
adding the sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) loading buffer. Proteins were separated by SDS-PAGE
(4-20%) and stained with Coomassie Brilliant Blue R-250. The
concentration of proteins was measured using the DC protein assay kit
(Bio-Rad) with bovine serum albumin as a standard.
Amino Acid Sequencing--
Amino acid sequences were determined
essentially according to the method of Matsudaira (24). Proteins were
subjected to SDS-PAGE and electrotransferred to a polyvinylidene
difluoride membrane (Schleicher & Schuell). The blotted membrane was
briefly stained with Coomassie Brilliant Blue R-250. After extensive
washing with water, membrane pieces containing the proteins of interest were excised and then examined with a Procise 492 gas-phase sequencer (Applied Biosystems Division, Perkin Elmer).
In Vitro Binding Assay--
GST or GST fusion proteins (2 µg
each) were immobilized on glutathione-Sepharose 4B beads (20 µl). CaM
(1 µg) was incubated with GST or GST fusion protein-immobilized beads
in 500 µl of Buffer B (25 mM Hepes, pH 7.4, 150 mM NaCl, and 1% Triton X-100) in the presence of either 2 mM CaCl2 or 5 mM EGTA without
addition of CaCl2 for 2 h at 4 °C. The beads were
washed with the incubation buffer, and bound proteins were eluted by
the SDS-PAGE loading buffer and incubated for 30 min at 60 °C.
Proteins were separated by SDS-PAGE (15% gel) and bound CaM was
visualized by immunoblotting with anti-CaM mAb. Chemiluminescence of
bound CaM was quantitated by densitometric analysis using The Discovery
Series (pdi, Huntington Station, NY). An affinity of CaM for binding to
GST fusion proteins was determined by immobilizing a fixed amount of a
GST fusion protein (60 pmol) on glutathione-Sepharose 4B beads,
followed by incubation with increasing concentrations of CaM. Bound CaM was immunoblotted after SDS-PAGE, and amounts of the bound CaM were
calculated from the standard curve with known amounts of CaM run on the
same gel. Densities of immunoblotted CaM showed a linear relationship
with known amounts of CaM, and each data point was obtained within the
linear range of the standard curve. Saturation curves were made by
fitting the data using the single site relationship B = Bmax × (F/Kd)/(1 + F/Kd), where B is the amount
bound, F is the amount free, Kd is the
dissociation constant, and Bmax represents the
maximal number of binding sites. Fitting and calculation of
Kd were done by using the Origin software (Microcal
Software, Northampton, MA).
Phosphorylation of Fusion Proteins--
GST fusion proteins (60 pmol) were incubated with none or increasing amounts of CaM for 2 h at 4 °C. For phosphorylation of PKC or PKA, the incubation mixture
(10 µl) contained 8.75 mM Hepes, pH 7.4, 52.5 mM NaCl, and 1 mM CaCl2.
Phosphorylation was started by addition of the following solution (10 µl): for PKC phosphorylation, 40 mM Tris-Cl, pH 7.5, 20 mM MgCl2, 200 µg/ml
L- Identification of an mGluR7-interacting Protein--
We attempted
to identify proteins that interact with mGluR7 by affinity
chromatography using the ct region of mGluR7 fused to GST. GST alone or
GST-ct-mGluR2 was used as control. Rat brain cytosolic fractions were
prepared and loaded to glutathione-Sepharose 4B beads coated with each
GST protein. After extensive washing, bound proteins were eluted by
addition of the SDS-PAGE loading buffer, separated by SDS-PAGE, and
stained with Coomassie Brilliant Blue R-250. A prominent band with a
mobility of approximately 17 kDa was detected in the eluate from
GST-ct-mGluR7 affinity beads (Fig. 1,
lane 2). No such 17-kDa protein was retained with affinity
beads attached with (lane 3) or without (lane 4)
GST. The specificity of interaction toward ct-mGluR7 was confirmed by
using GST-ct-mGluR2 which showed no detectable binding of the 17-kDa
protein (lane 1). Peptide sequencing of this 17-kDa protein and subsequent data base analysis indicated that the partial sequence determined
(Thr-Ile-Asp-Phe-Pro-Glu-Phe-Leu-Thr-Met-Met-Ala-Arg-Lys-Met-Lys-Asp) precisely corresponded to the sequence of rat CaM.
Characterization of CaM Binding to ct-mGluR7--
Next, we
examined the specificity of interaction between CaM and the ct regions
of group 2 and group 3 mGluRs using GST fusion protein affinity
chromatography. The GST proteins fused to the ct regions of group 2 and
group 3 mGluRs were immobilized on glutathione-Sepharose 4B beads and
tested for their ability to retain bovine CaM (Fig. 2, upper). CaM interacted
exclusively with ct-mGluR7. In contrast, no detectable interaction was
observed with group 2 ct-mGluRs and other members of group 3 ct-mGluRs
as well as GST alone. Furthermore, the interaction between CaM and
ct-mGluR7 was completely abolished by replacing 2 mM
CaCl2 with 5 mM EGTA in the binding solution. Staining of the SDS-polyacrylamide gel with Coomassie Brilliant Blue
R-250 confirmed that comparable amounts of GST or GST fusion proteins
were present in these experiments (Fig. 2, lower). The results indicate that among group 2 and group 3 mGluR subtypes, CaM
interacts specifically with ct-mGluR7 in a
Ca2+-dependent manner.
To define a CaM-interacting domain in ct-mGluR7, we constructed a
series of GST fusion proteins possessing different truncation forms of
ct-mGluR7 (Fig. 3A). The
truncated forms containing at least residues
Val856-Leu892 (Tr1-mGluR7 and Tr4-mGluR7)
showed a strong Ca2+-dependent interaction with
CaM comparable to that of ct-mGluR7 (Fig. 3B, upper). The
presence and absence of Cys893, which is implicated as a
possible palmitoylation site (25), had no effect on
Ca2+/CaM binding. In contrast, removal of a cluster of
basic residues at the amino-terminal region of ct-mGluR7 drastically
reduced Ca2+/CaM binding (Tr2-mGluR7 and Tr3-mGluR7). In
these experiments, comparable amounts of GST fusion proteins were
confirmed by Coomassie Brilliant Blue R-250 staining (Fig. 3B,
lower).
The affinity of Ca2+-dependent CaM binding to
ct-mGluR7 and Tr4-mGluR7 was determined by incubating a fixed amount of
the GST fusion proteins immobilized onto glutathione-Sepharose 4B beads with increasing concentrations of CaM in the presence of 2 mM CaCl2 (Fig. 4,
A and B). Analysis of saturation curves of bound CaM showed virtually identical values of dissociation constant (Kd) of CaM binding for ct-mGluR7 and Tr4-mGluR7,
38.9 ± 8.3 nM for ct-mGluR7 and 45.5 ± 13.6 nM for Tr4-mGluR7 (mean ± S.D., n = 2). The results indicate that the segment consisting of
Val856-Leu892 is sufficient for interaction
between CaM and ct-mGluR7.
Competition between PKC Phosphorylation and CaM Binding of mGluR7
in Vitro--
The CaM-binding domain in ct-mGluR7 contains consensus
sequences for both PKC phosphorylation,
(Ser/Thr)-X-(Arg/Lys), and PKA phosphorylation,
(Arg/Lys)-(Arg/Lys)-X-(Ser/Thr) (26). We examined whether
ct-mGluR7 serves as a phosphorylation substrate for PKC or PKA and, if
so, whether phosphorylation of these kinases and CaM binding are
mutually affected by each other. We first examined the effects of CaM
binding on PKC phosphorylation by incubating a fixed amount of either
GST-ct-mGluR7 or GST-Tr4-mGluR7 with PKC and [
Importantly, phosphorylation of both ct-mGluR7 and Tr4-mGluR7 was
progressively inhibited by adding increasing amounts of CaM to the
reaction mixture. At the molar ratio of 1:1 between the PKC substrates
and CaM, phosphorylation of both ct-mGluR7 and Tr4-mGluR7 was almost
completely inhibited by Ca2+/CaM. Furthermore, no obvious
difference in the sensitivity of inhibition of PKC phosphorylation by
Ca2+/CaM binding was observed between the two PKC
substrates. This finding is consistent with the results above, which
show a similar affinity of these mGluR7 segments for
Ca2+/CaM binding. The results indicate that the interaction
of Ca2+/CaM with the ct domain of mGluR7 prevents
phosphorylation by PKC.
Finally, we examined the effect of PKC phosphorylation on
Ca2+/CaM binding to ct-mGluR7 (Fig.
6). GST-ct-mGluR7 or GST-Tr4-mGluR7 was
incubated with PKC in the presence and absence of ATP. The resultant
GST fusion proteins were coupled to glutathione-Sepharose 4B beads and
tested for their ability to bind to CaM in a
Ca2+-dependent manner. Non-phosphorylated GST
fusion proteins could bind to Ca2+/CaM, but once
phosphorylated, they lost their ability to bind to
Ca2+/CaM. The results indicate that Ca2+/CaM
binding is inhibited by PKC phosphorylation.
In this study, in vitro analysis indicates that CaM
directly binds to ct-mGluR7 in a Ca2+-dependent
fashion. Among the mGluR family, mGluR5 has been shown to interact with
Ca2+/CaM at two distinct sites of ct-mGluR5 with different
affinities (27). Consistent with the sequence homology between mGluR1
and mGluR5, we have found that Ca2+/CaM also binds to
ct-mGluR1.2 Interestingly,
the group 3 mGluR subtypes (mGluR4, mGluR7, and mGluR8) have highly
homologous ct tails, but no significant interaction was observed
between CaM and mGluR4 or mGluR8. Therefore, the binding of
Ca2+/CaM is specific to group 1 mGluRs and mGluR7 within
the mGluR family and thus is not relevant to intracellular second
messengers involving these receptor subtypes. The CaM-binding domain of
ct-mGluR7 diverges from those of group 1 mGluRs but possesses several
structural characteristics of CaM binding (28) as follows: 1) one face possessing basic and polar residues in an The CaM-binding domain of mGluR7 has been located within a segment
immediately downstream of the 7th transmembrane segment and upstream of
Cys893 in ct-mGluR7. This cysteine residue is commonly
present in the ct of group 3 mGluRs (mGluR4, mGluR7, and mGluR8) (Fig.
3) and has been reported to be a putative palmitoylation site, for
example in mGluR4 (25). Such palmitoylation is thought to be involved in the formation of the 4th intracellular loop structure. For mGluR5,
one of the two CaM-binding domains resides at the corresponding portion
immediately following the 7th transmembrane segment (27). This domain
of mGluRs, together with their 2nd cytoplasmic loop, has been shown to
serve as a G protein-interacting domain (29, 30). Therefore, the
overlap of a CaM-binding domain and the G protein-interacting domain
suggests an interesting possibility that CaM binding to specific mGluR
subtypes may also affect a G protein coupling efficacy.
In this study, using in vitro analysis we have demonstrated
that ct-mGluR7 is phosphorylated by PKC but not by PKA. Furthermore, CaM binding and PKC phosphorylation are mutually exclusive. There are
several precedents that have shown a similar relationship between CaM
binding and phosphorylation by PKC. For example, in mGluR5, PKC
phosphorylation is inhibited by Ca2+/CaM binding to the
receptor, and conversely this binding is prevented by PKC
phosphorylation (27). In the
N-methyl-D-aspartate (NMDA) glutamate receptors,
binding of Ca2+/CaM disrupts an interaction between NMDA
receptors and the cytoskeletal *
This work was supported in part by research grants from the
Ministry of Education, Science and Culture of Japan, the Sankyo Foundation, the Yamanouchi Foundation, and the Biomolecular Engineering Research Institute.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
K. Ishikawa, Y. Nakajima, and S. Nakanishi,
unpublished observations.
The abbreviations used are:
mGluR, metabotropic
glutamate receptor;
IP3, inositol trisphosphate;
L-AP4, L-2-amino-4-phosphonobutyrate;
ct, carboxyl terminus;
GST, glutathione S-transferase;
kDa, kilodalton;
CaM, calmodulin;
PKC, protein kinase C;
anti-CaM mAb, mouse
monoclonal antibody against CaM;
PKA, protein kinase A;
PCR, polymerase
chain reaction;
PAGE, polyacrylamide gel electrophoresis;
[Ca2+]i, intracellular Ca2+
concentration;
Kd, dissociation constant;
MARCKS, myristoylated alanine-rich protein kinase C substrate;
NMDA, Nmethyl-D-aspartate;
MES, 2-(N-morpholino)ethanesulfonic acid.
Department of Cell Physiology,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP from Amersham Pharmacia Biotech.
-phosphatidyl-L-serine, 40 µg/ml
1,2-dioleoyl-sn-glycerol, 200 µM
[
-32P]ATP (50 mCi/mmol), and 9.6 milliunits of PKC;
for PKA phosphorylation, 100 mM MES, pH 6.9, 20 mM MgCl2, 2 mg/ml bovine serum albumin, 2 mM dithiothreitol, 400 µM
[
-32P]ATP (50 mCi/mmol), and 10 microunits of
catalytic subunit of PKA. Reactions were carried out at 30 °C for
the times indicated and stopped by boiling in the SDS-PAGE loading
buffer. The phosphorylated proteins were separated by SDS-PAGE (15%
gel), fixed, dried, and finally exposed to an x-ray film. To determine
effects of PKC phosphorylation on CaM binding, each of the fusion
proteins (2 µg) was phosphorylated for 3 h at 30 °C as
described above except that [
-32P]ATP was replaced
with non-labeled ATP. As a control, ATP was depleted in the
phosphorylation reaction.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (60K):
[in a new window]
Fig. 1.
SDS-PAGE analysis showing specific binding of
ct-mGluR7 to CaM in brain extracts. Rat brain cytosolic extracts
were incubated with glutathione-Sepharose 4B beads attached with GST or
GST-ct-mGluRs. Proteins retained by these beads were eluted, separated
by SDS-PAGE (4-20% gradient gel), and stained with Coomassie
Brilliant Blue R-250. The following GST or GST fusion proteins were
immobilized on beads: lane 1, GST-ct-mGluR2; lane
2, GST-ct-mGluR7; lane 3, GST alone; lane 4,
without any immobilized GST proteins. Lane M, molecular mass
markers (kDa).

View larger version (31K):
[in a new window]
Fig. 2.
Selective
Ca2+-dependent binding of CaM to
ct-mGluR7. The whole ct regions of group 2 and group 3 mGluRs as
indicated by numbers were fused to GST. The resultant GST
fusion proteins or GST alone were immobilized on glutathione-Sepharose
4B beads and tested for their ability to bind to CaM in the presence of
either 2 mM CaCl2 or 5 mM EGTA
without addition of CaCl2. One-fifth of bound proteins was
separated by SDS-PAGE, and bound CaM was detected by immunoblotting
with anti-CaM mAb in the upper panel. CaM (100 ng) was run
as a control (control lane). Sizes of molecular mass markers
(kDa) are shown on the left. The lower panel
shows a Coomassie Brilliant Blue R-250 staining of the GST or GST
fusion proteins immobilized on glutathione-Sepharose 4B beads.

View larger version (45K):
[in a new window]
Fig. 3.
Identification of the CaM-binding domain in
ct-mGluR7. A, amino acid sequences of ct-mGluR7,
ct-mGluR4, and ct-mGluR8 and various truncated forms
(Tr1-Tr4) of ct-mGluR7. A cluster of basic amino acids at
the amino-terminal region (
), 4 serine residues showing possible PKC
phosphorylation sites (
), and a cysteine residue indicating a
putative palmitoylation site (*) are marked above the
ct-mGluR7 sequence. Amino acids identical between mGluR4, mGluR7, and
mGluR8 are indicated by line connections. B, in
the upper panel, binding of CaM to GST, GST-ct-mGluR7, and
four different GST-Tr-mGluRs was analyzed in the presence of either 2 mM CaCl2 or 5 mM EGTA. In the
lower panel, the amounts of GST or GST fusion proteins
immobilized on beads are shown. For other explanations, see Fig. 2
legend.

View larger version (12K):
[in a new window]
Fig. 4.
Determination of affinities of CaM binding to
ct-mGluR7 and Tr4-mGluR7. GST-ct-mGluR7 (A) and
GST-Tr4-mGluR7 (B) (60 pmol each) were immobilized on
glutathione-Sepharose 4B beads and incubated with increasing
concentrations of CaM in the presence of 2 mM
CaCl2. Amounts of bound CaM were determined from
densitometric analysis of immunoblotting with anti-CaM mAb after
SDS-PAGE. Data points and bars show mean ± S.D., respectively, in representative experiments done in
duplicate.
-32P]ATP
in the absence and presence of increasing concentrations of CaM. Time
courses and extents of phosphorylation of ct-mGluR7 or Tr4-mGluR7 were
determined by autoradiography of a 32P-labeled product run
on an SDS-polyacrylamide gel (Fig. 5). In the absence of CaM, both ct-mGluR7 and Tr4-mGluR7 were rapidly phosphorylated in a time-dependent manner with about
one-third of the proteins estimated to be phosphorylated at 1 h in
both cases. Neither GST nor CaM was phosphorylated by PKC. Furthermore, there was no obvious difference in the time course and extent of PKC
phosphorylation between ct-mGluR7 (Fig. 5A) and Tr4-mGluR7 (Fig. 5B). We also examined possible PKA phosphorylation of
GST-ct-mGluR7 by incubating with PKA and [
-32P]ATP.
Regardless of the presence and absence of Ca2+/CaM,
GST-ct-mGluR7 was not appreciably phosphorylated by PKA (data not
shown). These results show that the CaM-binding domain is a major site
of PKC phosphorylation within the ct-mGluR7 sequence. In contrast, this
site does not serve as a target for PKA phosphorylation.

View larger version (28K):
[in a new window]
Fig. 5.
Inhibitory effect of Ca2+/CaM
binding on PKC phosphorylation of GST-ct-mGluR7 and
GST-Tr4-mGluR7. A fixed amount of GST-ct-mGluR7 (A) and
GST-Tr4-mGluR7 (B) (60 pmol each) was incubated with PKC and
[
-32P]ATP in the absence and presence of increasing
amounts of CaM (18, 60, and 180 pmol) as indicated with molar ratios
between the GST fusion proteins and CaM. The reaction was terminated at
the indicated times (min), and the reaction product was subjected to
SDS-PAGE, followed by autoradiography of a 32P-labeled
product. GST alone was also subjected to the phosphorylation reaction
in the absence of CaM and run on SDS-PAGE (lane GST).
Molecular sizes (kDa) of marker proteins are shown on the
left.

View larger version (36K):
[in a new window]
Fig. 6.
Inhibitory effect of PKC phosphorylation on
Ca2+/CaM binding to ct-mGluR7. GST-ct-mGluR7,
GST-Tr4-mGluR7, and GST alone (2 µg each) were subjected to PKC
phosphorylation reaction for 3 h in the presence and absence of
ATP. The resultant GST fusion proteins or GST alone were immobilized on
glutathione-Sepharose 4B beads and tested for their ability to bind to
CaM in the presence of either 2 mM CaCl2 or 5 mM EGTA. The lower panel shows a Coomassie
Brilliant Blue R-250 staining, indicating no difference in retention of
the phosphorylated and non-phosphorylated proteins on the glutathione
beads.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical wheel
representation, whereas the other face contains a stretch of
hydrophobic amino acids; 2) a cluster of basic amino acids at the
amino-terminal portion, followed by a sequence that contains relatively
few basic amino acids but often possesses a consensus sequence for
phosphorylation (Fig. 3). Interestingly, some of these features are
shared by mGluR4 and mGluR8. However, these two subtypes show no
appreciable interaction with Ca2+/CaM. Therefore, amino
acid differences in the middle of the CaM-binding sequence of mGluR7 as
compared with mGluR4 and mGluR8 (Fig. 3) seem to be critical for their
ability to bind to Ca2+/CaM.
-actinin-2 (31, 32). Additionally,
the CaM binding and protein phosphorylation in NMDA receptors have been
reported to be mutually exclusive (33). In both cases, the
intracellular Ca2+ concentration
([Ca2+]i) is raised by activation of these
receptors, either by the enhancement of Ca2+ influx through
a receptor-channel complex or by mobilization of intracellular
Ca2+ stores via IP3 production. These examples
therefore differ from the signaling mechanism of mGluR7, which is
coupled to the inhibitory cyclic AMP cascade and has no ability to
stimulate IP3 formation or influence Ca2+
influx directly (10). In this sense, the reciprocal regulation between
CaM binding and PKC phosphorylation of mGluR7 is more reminiscent to
the regulation of myristoylated alanine-rich protein kinase C substrate
(MARCKS) by the Ca2+/CaM binding and protein
phosphorylation. MARCKS is a major cellular substrate of PKC, with PKC
phosphorylation inhibiting CaM binding and CaM binding preventing PKC
phosphorylation. The brain MARCKS is highly concentrated at the
presynaptic junction and is thought to be phosphorylated by PKC through
an increase in [Ca2+]i triggered by neuronal cell
stimulation (34). It has recently been reported that activation of PKC
suppresses the ability of group 3 mGluRs to inhibit transmission at
glutamatergic synapses (13). Furthermore, mGluR7 is largely located at
the presynaptic terminals. Therefore, it is conceivable that mGluR7 is
under dual regulation by PKC and CaM at the presynaptic terminals, when
neuronal cells are stimulated and increase a Ca2+ influx
through activated Ca2+ channels. Thus, our observations
suggest that mGluR7 serves to cross-link the cyclic AMP,
Ca2+, and PKC phosphorylation signal transduction cascades.
In closing, this process may play an important role in modulating
synaptic transmission in concert with the function of CaM which
recognizes changes in [Ca2+]i.
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of
Biological Sciences, Kyoto University Faculty of Medicine, Yoshida,
Sakyo-ku, Kyoto 606-8501, Japan. Tel.: 81-75-753-4437; Fax:
81-75-753-4404; E-mail: snakanis@phy.med.kyoto-u.ac.jp.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Nakanishi, S.
(1992)
Science
258,
597-603 2.
Nakanishi, S.
(1994)
Neuron
13,
1031-1037[CrossRef][Medline]
[Order article via Infotrieve]
3.
Pin, J.-P.,
and Duvoisin, R.
(1995)
Neuropharmacology
34,
1-26[CrossRef][Medline]
[Order article via Infotrieve]
4.
Conn, P. J.,
and Pin, J.-P.
(1997)
Annu. Rev. Pharmacol. Toxicol.
37,
205-237[CrossRef][Medline]
[Order article via Infotrieve]
5.
Makoff, A.,
Pilling, C.,
Harrington, K.,
and Emson, P.
(1996)
Brain Res. Mol. Brain Res.
40,
165-170[Medline]
[Order article via Infotrieve]
6.
Kinzie, J. M.,
Saugstad, J. A.,
Westbrook, G. L.,
and Segerson, T. P.
(1995)
Neuroscience
69,
167-176[CrossRef][Medline]
[Order article via Infotrieve]
7.
Ohishi, H.,
Akazawa, C.,
Shigemoto, R.,
Nakanishi, S.,
and Mizuno, N.
(1995)
J. Comp. Neurol.
360,
555-570[CrossRef][Medline]
[Order article via Infotrieve]
8.
Bradley, S. R.,
Levey, A. I.,
Hersch, S. M.,
and Conn, P. J.
(1996)
J. Neurosci.
16,
2044-2056 9.
Kinoshita, A.,
Shigemoto, R.,
Ohishi, H.,
van der Putten, H.,
and Mizuno, N.
(1998)
J. Comp. Neurol.
393,
332-352[CrossRef][Medline]
[Order article via Infotrieve]
10.
Okamoto, N.,
Hori, S.,
Akazawa, C.,
Hayashi, Y.,
Shigemoto, R.,
Mizuno, N.,
and Nakanishi, S.
(1994)
J. Biol. Chem.
269,
1231-1236 11.
Saugstad, J. A.,
Kinzie, J. M.,
Mulvihill, E. R.,
Segerson, T. P.,
and Westbrook, G. L.
(1994)
Mol. Pharmacol.
45,
367-372[Abstract]
12.
Macek, T. A.,
Winder, D. G.,
Gereau, R. W., IV,
Ladd, C. O.,
and Conn, P. J.
(1996)
J. Neurophysiol.
76,
3798-3806 13.
Macek, T. A.,
Schaffhauser, H.,
and Conn, P. J.
(1998)
J. Neurosci.
18,
6138-6146 14.
Shigemoto, R.,
Kulik, A.,
Roberts, J. D. B.,
Ohishi, H.,
Nusser, Z.,
Kaneko, T.,
and Somogyi, P.
(1996)
Nature
381,
523-525[CrossRef][Medline]
[Order article via Infotrieve]
15.
Shigemoto, R.,
Kinoshita, A.,
Wada, E.,
Nomura, S.,
Ohishi, H.,
Takada, M.,
Flor, P. J.,
Neki, A.,
Abe, T.,
Nakanishi, S.,
and Mizuno, N.
(1997)
J. Neurosci.
17,
7503-7522 16.
Bushell, T. J.,
Sansig, G.,
Shigemoto, R.,
Flor, P.,
Kuhn, R.,
Knoepfel, T.,
Schroeder, M.,
Collett, V. L.,
Collingridge, G. L.,
and van der Putten, H.
(1996)
Neuropharmacology
35,
A6
17.
Masugi, M.,
Yokoi, M.,
Shigemoto, R.,
Muguruma, K.,
Watanabe, Y.,
Sansig, G.,
van der Putten, H.,
and Nakanishi, S.
(1999)
J. Neurosci.
19,
955-963 18.
Brakeman, P. R.,
Lanahan, A. A.,
O'Brien, R.,
Roche, K.,
Barnes, C. A.,
Huganir, R. L.,
and Worley, P. F.
(1997)
Nature
386,
284-288[CrossRef][Medline]
[Order article via Infotrieve]
19.
Xiao, B.,
Tu, J. C.,
Petralia, R. S.,
Yuan, J. P.,
Doan, A.,
Breder, C. D.,
Ruggiero, A.,
Lanahan, A. A.,
Wenthold, R. J.,
and Worley, P. F.
(1998)
Neuron
21,
707-716[CrossRef][Medline]
[Order article via Infotrieve]
20.
Tu, J. C.,
Xiao, B.,
Yuan, J. P.,
Lanahan, A. A.,
Leoffert, K.,
Li, M.,
Linden, D. J.,
and Worley, P. F.
(1998)
Neuron
21,
717-726[CrossRef][Medline]
[Order article via Infotrieve]
21.
Tanabe, Y.,
Masu, M.,
Ishii, T.,
Shigemoto, R.,
and Nakanishi, S.
(1992)
Neuron
8,
169-179[CrossRef][Medline]
[Order article via Infotrieve]
22.
Nakajima, Y.,
Iwakabe, H.,
Akazawa, C.,
Nawa, H.,
Shigemoto, R.,
Mizuno, N.,
and Nakanishi, S.
(1993)
J. Biol. Chem.
268,
11868-11873 23.
Saugstad, J. A.,
Kinzie, J. M.,
Shinohara, M. M.,
Segerson, T. P.,
and Westbrook, G. L.
(1997)
Mol. Pharmacol.
51,
119-125 24.
Matsudaira, P.
(1987)
J. Biol. Chem.
262,
10035-10038 25.
Alaluf, S.,
Mulvihill, E. R.,
and McIlhinney, R. A. J.
(1995)
J. Neurochem.
64,
1548-1555[Medline]
[Order article via Infotrieve]
26.
Kennelly, P. J.,
and Krebs, E. G.
(1991)
J. Biol. Chem.
266,
15555-15558 27.
Minakami, R.,
Jinnai, N.,
and Sugiyama, H.
(1997)
J. Biol. Chem.
272,
20291-20298 28.
James, P.,
Vorherr, T.,
and Carafoli, E.
(1995)
Trends Biochem. Sci.
20,
38-42[CrossRef][Medline]
[Order article via Infotrieve]
29.
Pin, J.-P.,
Joly, C.,
Heinemann, S. F.,
and Bockaert, J.
(1994)
EMBO J.
13,
342-348[Medline]
[Order article via Infotrieve]
30.
Gomeza, J.,
Joly, C.,
Kuhn, R.,
Knöpfel, T.,
Bockaert, J.,
and Pin, J.-P.
(1996)
J. Biol. Chem.
271,
2199-2205 31.
Wyszynski, M.,
Lin, J.,
Rao, A.,
Nigh, E.,
Beggs, A. H.,
Craig, A. M.,
and Sheng, M.
(1997)
Nature
385,
439-442[CrossRef][Medline]
[Order article via Infotrieve]
32.
Zhang, S.,
Ehlers, M. D.,
Bernhardt, J. P.,
Su, C.-T.,
and Huganir, R. L.
(1998)
Neuron
21,
443-453[CrossRef][Medline]
[Order article via Infotrieve]
33.
Ehlers, M. D.,
Zhang, S.,
Bernhardt, J. P.,
and Huganir, R. L.
(1996)
Cell
84,
745-755[CrossRef][Medline]
[Order article via Infotrieve]
34.
Aderem, A.
(1992)
Cell
71,
713-716[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
This article has been cited by other articles:
![]() |
A. Scheschonka, S. Findlow, R. Schemm, O. El Far, J. H. Caldwell, M. P. Crump, K. Holden-Dye, V. O'Connor, H. Betz, and J. M. Werner Structural Determinants of Calmodulin Binding to the Intracellular C-terminal Domain of the Metabotropic Glutamate Receptor 7A J. Biol. Chem., February 29, 2008; 283(9): 5577 - 5588. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Turner and J. R. Raymond Interaction of Calmodulin with the Serotonin 5-Hydroxytryptamine2A Receptor: A PUTATIVE REGULATOR OF G PROTEIN COUPLING AND RECEPTOR PHOSPHORYLATION BY PROTEIN KINASE C J. Biol. Chem., September 2, 2005; 280(35): 30741 - 30750. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Belcheva, A. L. Clark, P. D. Haas, J. S. Serna, J. W. Hahn, A. Kiss, and C. J. Coscia {micro} and {kappa} Opioid Receptors Activate ERK/MAPK via Different Protein Kinase C Isoforms and Secondary Messengers in Astrocytes J. Biol. Chem., July 29, 2005; 280(30): 27662 - 27669. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Nickols, V. N. Shah, W. J. Chazin, and L. E. Limbird Calmodulin Interacts with the V2 Vasopressin Receptor: ELIMINATION OF BINDING TO THE C TERMINUS ALSO ELIMINATES ARGININE VASOPRESSIN-STIMULATED ELEVATION OF INTRACELLULAR CALCIUM J. Biol. Chem., November 5, 2004; 279(45): 46969 - 46980. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bhave, B. M. Nadin, D. J. Brasier, K. S. Glauner, R. D. Shah, S. F. Heinemann, F. Karim, and R. W. Gereau IV Membrane Topology of a Metabotropic Glutamate Receptor J. Biol. Chem., August 8, 2003; 278(32): 30294 - 30301. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. J. Gordon and J. S. Bains Priming of Excitatory Synapses by {alpha}1 Adrenoceptor-Mediated Inhibition of Group III Metabotropic Glutamate Receptors J. Neurosci., July 16, 2003; 23(15): 6223 - 6231. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kitano, Y. Yamazaki, K. Kimura, T. Masukado, Y. Nakajima, and S. Nakanishi Tamalin Is a Scaffold Protein That Interacts with Multiple Neuronal Proteins in Distinct Modes of Protein-Protein Association J. Biol. Chem., April 18, 2003; 278(17): 14762 - 14768. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sorensen, T. A. Macek, Z. Cai, J. A. Saugstad, and P. J. Conn Dissociation of Protein Kinase-Mediated Regulation of Metabotropic Glutamate Receptor 7 (mGluR7) Interactions with Calmodulin and Regulation of mGluR7 Function Mol. Pharmacol., June 1, 2002; 61(6): 1303 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sansig, T. J. Bushell, V. R. J. Clarke, A. Rozov, N. Burnashev, C. Portet, F. Gasparini, M. Schmutz, K. Klebs, R. Shigemoto, et al. Increased Seizure Susceptibility in Mice Lacking Metabotropic Glutamate Receptor 7 J. Neurosci., November 15, 2001; 21(22): 8734 - 8745. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Dev, Y. Nakajima, J. Kitano, S. P. Braithwaite, J. M. Henley, and S. Nakanishi PICK1 Interacts with and Regulates PKC Phosphorylation of mGLUR7 J. Neurosci., October 1, 2000; 20(19): 7252 - 7257. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schaffhauser, Z. Cai, F. Hubalek, T. A. Macek, J. Pohl, T. J. Murphy, and P. J. Conn cAMP-Dependent Protein Kinase Inhibits mGluR2 Coupling to G-Proteins by Direct Receptor Phosphorylation J. Neurosci., August 1, 2000; 20(15): 5663 - 5670. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bofill-Cardona, O. Kudlacek, Q. Yang, H. Ahorn, M. Freissmuth, and C. Nanoff Binding of Calmodulin to the D2-Dopamine Receptor Reduces Receptor Signaling by Arresting the G Protein Activation Switch J. Biol. Chem., October 13, 2000; 275(42): 32672 - 32680. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Belcheva, M. Szucs, D. Wang, W. Sadee, and C. J. Coscia {micro}-Opioid Receptor-mediated ERK Activation Involves Calmodulin-dependent Epidermal Growth Factor Receptor Transactivation J. Biol. Chem., August 31, 2001; 276(36): 33847 - 33853. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. El Far, E. Bofill-Cardona, J. M. Airas, V. O'Connor, S. Boehm, M. Freissmuth, C. Nanoff, and H. Betz Mapping of Calmodulin and Gbeta gamma Binding Domains within the C-terminal Region of the Metabotropic Glutamate Receptor 7A J. Biol. Chem., August 10, 2001; 276(33): 30662 - 30669. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |